In an MCAO model study, 11-keto-β-boswellic acid (KBA) activated the Nrf2 pathway in a concentration-dependent manner, therefore significantly inhibiting the level of ROS derived from astrocytes and reducing the volume of cerebral infarction and alleviating the dysfunction of the brain. Here, NFE2L2 is linked to brain infarction.